Jump to main content.

shopping cart


Regulatory Impact Assessment of Proposed Effluent Guidelines for the Pharmaceutical Manufacturing Industry

EPA Number: 821R95017
Date of Publication:Febuary, 1995
Audienceconcerned citizens, industry

Available from:
NSCEPGo to the NSCEP Shopping Cart
NTIS# PB95-219812Ordering Information
The report has been prepared to comply with Executive Order 12866, which requires federal agencies to assess the costs and benefits of each significant rule they propose or promulgate. More...

Drug Industry
Water Pollution Control
Economic Impact
Chemical Effluents
Industrial Plants
Pollution Regulations
Cost Benefit Analysis
Pharmaceutical Industry

Jump to main content.